- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Case Reports in Medicine
Volume 2010 (2010), Article ID 314547, 3 pages
A Case of Villoglandular Papillary Adenocarcinoma of the Uterine Cervix Diagnosed during Early Pregnancy Followed by Successful Term Delivery
1Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 879-5593, Japan
2Department of Obstetrics and Gynecology, Oita Prefectural Hospital, 476 Bu-nyo, Oita 870-8511, Japan
Received 9 January 2010; Revised 25 March 2010; Accepted 19 May 2010
Academic Editor: Debra S. Heller
Copyright © 2010 Noriyuki Takai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Villoglandular papillary adenocarcinoma (VPA) is a very rare subtype of adenocarcinoma of the uterine cervix, but a well-recognized variant of cervical adenocarcinoma with a favorable prognosis and generally occurring in women of child-bearing age. Only five cases of VPA and pregnancy have been reported. Herein, we report a case of VPA diagnosed during early pregnancy and managed successfully with conservative measures; our patient delivered a healthy baby in full term. A successful pregnancy can be completed in patients with VPA without lymph-vascular invasion, when treated conservatively. This management is particularly desirable in young women to preserve reproductive capability.
The incidence of cervical adenocarcinoma is on the rise over the last decades. Villoglandular papillary adenocarcinoma (VPA) is a very rare subtype of adenocarcinoma of the uterine cervix. The true incidence of this form of adenocarcinoma is unknown. The classical histologic appearance of this entity is a surface papillary component of variable thickness with papillae that are usually tall and thin, but occasionally short and broad, with a fibrous stromal core. The tumor cells should have no more than mild-to-moderate nuclear atypicality and scattered mitotic figures. It affects a younger age group and has an excellent prognosis as compared to other endocervical adenocarcinomas [1, 2]. To our knowledge, only five cases of VPA associated with pregnancies have been reported in the literature [3–7]. In two cases, the patients were diagnosed VPA during pregnancy followed by conservative treatment and delivered healthy children [5, 7]. We report here a successful term pregnancy with stage IB VPA of the cervix diagnosed during early pregnancy.
2. Case Report
A 28-year-old Japanese woman, gravida 1, para 1, was admitted with atypical genital bleeding and underwent polypectomy of the uterine cervix at 9 weeks’ gestation. The 1-cm resected polyp was pathologically diagnosed as VPA (Figure 1). The tumor is purely exophytic without invasion of the underlying stroma and lymphvascular involvement. Hence, she was referred to our hospital. As the polyp had no lymph capillary space invasion, we performed conization at 16 weeks’ gestation when the patient decided to continue her pregnancy. The depth of surgical specimen was 1 cm and width of that was 3 cm diameter. No cancer cells were identified in the resected specimens. The final diagnosis was FIGO stage IB1. She delivered a healthy 2,946 g newborn vaginally at term 38 weeks, and she has been free of the disease for 44 months.
We report an extremely rare case who was diagnosed VPA in the 1st trimester and was managed conservatively throughout the pregnancy with successful results for both the mother and the baby. VPA of the uterine cervix is a rare form of cervical adenocarcinoma first described by Young and Scully in 1989 . They found that this tumor has an excellent prognosis and suggested conization as a potential treatment for patients of childbearing age . Conservative management of cervical VPA is considered to be a significant challenge; however, the English literature concerning treatment of VPA diagnosed during pregnancy is sparse. So far, over 115 cases of cervical VPAs have been reported worldwide; of these only nine metastases and two deaths were reported [7–11]. These few cases show an apparent discrepancy from the excellent prognosis of VPA described originally by Young, Scully and others [1, 12]. In 30% of cases, VPA is associated with other forms of invasive cancer [1–4, 6], which may have an important impact on the prognosis. Young and Scully therefore reserve the term VPA for tumors in which the villoglandular pattern is the exclusive or almost exclusive one. It has been suggested that in cases of superficial VPA diagnosed in young patients, unassociated with another type of cervical tumor and without lymph vascular invasion, less radical treatment may be suitable since these cases present a favorable outcome . However, since the knowledge of the biologic spectrum of VPA appears to be evolving, a close follow up should be pursued in VPA patients managed conservatively .
Young and Scully recommended careful inspection of the histological specimen and if the villoglandular component is the exclusive or almost exclusive pattern then a diagnosis of VPA can be ascribed . Other papillary adenocarcinomas can present a difficulty in diagnosis. Serous papillary adenocarcinomas of the cervix have finer, more irregular and more cellular papillae than VPA. The clear cell papillary adenocarcinomas of the cervix are characterized by marked cytological atypia, high mitotic activity and occasionally the presence of psammoma bodies. VPA should be distinguished from endocervical adenocarcinoma with a minor villoglandular component. The rare adenosarcoma and adenoma malignum should also be considered in the differential diagnosis of VPA .
Pregnancy associated with VPA of the cervix has been reported in only five cases [3–7]. In two cases, successful pregnancies were achieved following a conservative treatment for VPA [3, 4]. Three additional cases were diagnosed during pregnancy (Table 1); the first case, which was diagnosed during the 20th week of gestation, was conservatively followed until the 32nd week of gestation, when a caesarean radical hysterectomy was performed , the second case ended with an early induced abortion (8 weeks of gestation) followed by a radical hysterectomy , and the third case, which was diagnosed during the 13th week of gestation, was conservatively followed until the 37th week of gestation, when a caesarean radical hysterectomy was performed . In the case whose pregnancy was terminated (8 weeks of gestation) followed by a radical hysterectomy, the patient underwent second, third and fourth laparotomies because of recurrent pelvic masses. At the end of five years follow-up period, she died because of the complication of recurrent tumor . Bouman et al. reported three cases of VPA, and two of these are malicious because they have other histological features (the first case showed well-differentiated adenocarcinoma with abundant squamous differentiation, and the second case has well to moderately differentiated papillary adenocarcinoma) . These authors recommend the attitude, “Beware of a wolf in sheep’s clothing”, in relation to VPA . However, we can not discuss the clinical outcome in pregnant patients, because there is no report of VPA accompanied with other histological features or extended tumor invasion in pregnant patients.
In conclusion, despite the limited experience of cervical VPA diagnosed during pregnancy, conservative treatment can be successfully achieved in selected patients after a thorough evaluation of the depth of invasion, the lymph vascular involvement, and the association of other carcinoma histologies in conjunction with the VPA (i.e. adenocarcinoma or squamous cell carcinoma).
- R. H. Young and R. E. Scully, “Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases,” Cancer, vol. 63, no. 9, pp. 1773–1779, 1989.
- M. W. Jones, S. G. Silverberg, and R. J. Kurman, “Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a clinicopathological study of 24 cases,” International Journal of Gynecological Pathology, vol. 12, no. 1, pp. 1–7, 1993.
- J. S. Hoffman, L. Bazzurini, L. Laird, J. C. Murphy, U. Magriples, and J. Lewis, “Term delivery following conservative treatment for villoglandular papillary adenocarcinoma of the uterine cervix: report of a case and analysis of the literature,” Gynecologic Oncology, vol. 81, no. 2, pp. 310–313, 2001.
- O. Falcón, R. García, A. Lubrano, J. C. Morín, and M. Andujar, “Successful term delivery following conservative management for villoglandular papillary adenocarcinoma of the uterine cervix: a case report,” Gynecologic Oncology, vol. 101, no. 1, pp. 168–171, 2006.
- J. A. Hurteau, G. C. Rodriguez, H. H. Kay, R. C. Bentley, and D. Clarke-Pearson, “Villoglandular adenocarcinoma of the cervix: a case report,” Obstetrics and Gynecology, vol. 85, no. 5, part 2, pp. 906–908, 1995.
- M. Dede, G. Deveci, M. S. Deveci, M. C. Yenen, U. Goktolga, S. Dilek, and O. Gunhan, “Villoglandular papillary adenocarcinoma of the uterine cervix in a pregnant women: a case report and review of literature,” Tohoku Journal of Experimental Medicine, vol. 202, no. 4, pp. 305–310, 2004.
- O. Lavie, Y. Segev, G. Peer, E. Gutterman, S. Sagie, and R. Auslnader, “Conservative management for villoglandular papillary adenocarcinoma of the cervix diagnosed during pregnancy followed by a successful term delivery: a case report and a review of the literature,” European Journal of Surgical Oncology, vol. 34, no. 5, pp. 606–608, 2008.
- A. Garcea, D. Nunns, D. Ireland, and L. Brown, “A case of villoglandular papillary adenocarcinoma of the cervix with lymph node metastasis,” British Journal of Obstetrics and Gynaecology, vol. 110, no. 6, pp. 627–629, 2003.
- S. Khunamornpong, S. Maleemonkol, S. Siriaunkgul, and A. Pantusart, “Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a report of 15 cases including two with lymph node metastasis,” Journal of the Medical Association of Thailand, vol. 84, no. 6, pp. 882–888, 2001.
- R. D. Macdonald, J. Kirwan, K. Hayat, C. S. Herrington, and H. Shawki, “Villoglandular adenocarcinoma of the cervix: clarity is needed on the histological definition for this difficult diagnosis,” Gynecologic Oncology, vol. 100, no. 1, pp. 192–194, 2006.
- T. Kaku, T. Kamura, and T. Kamura, “Adenocarcinoma of the uterine cervix with predominantly villogladular papillary growth pattern,” Gynecologic Oncology, vol. 64, no. 1, pp. 147–152, 1997.
- K. Utsugi, Y. Shimizu, F. Akiyama, S. Umezawa, and K. Hasumi, “Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix,” Gynecologic Oncology, vol. 92, no. 1, pp. 64–70, 2004.
- O. Fadare and W. Zheng, “Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix with a focal high-grade component: is there a need for reassessment?” Virchows Archiv, vol. 447, no. 5, pp. 883–887, 2005.
- A. Bouman, G. J. E. Oosterhuis, L. Naudin Ten Cate, and G. A. van Doorn, “Villoglandular papillary adenocarcinoma of the cervix: beware of a wolf in sheep's clothing,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 87, no. 2, pp. 183–189, 1999.